chevron_leftBack
As of 13 June 2026, Median Diagnostics Inc. has a market cap of $8.85M USD, ranking #41922 globally and #2600 in South Korea.
It ranks #3712 in the Healthcare sector, and #781 in the Medical Devices industry.
Key Stats
Market Cap
$8.85MUSD
13.46B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.7% | -2.4% | -4.7% | -15% | -29% | -34% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
233250
(주)메디안디노스틱
ISIN: KR7233250000
Shares Out.:
Shares Outstanding:
1.647M1
Shares Float:
272.473K2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8,200 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.47B
28K%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.23B
14K%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.19B
13K%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.14B
13K%
1.74T KRW
|
-
|
|
KRX: 096530
|
$759.58M
8K%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$532.37M
6K%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
2M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
2M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
2M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
1M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
1M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
1M%
|
22.2
|
chevron_leftBack